Key Takeaways

  • The opioid epidemic killed over 500,000 Americans between 1999 and 2020, with deaths continuing at high rates driven by illicit fentanyl.
  • Purdue Pharma aggressively marketed OxyContin knowing it was highly addictive, used misleading claims about its safety, and paid doctors to prescribe it.
  • The Sackler family, which owned Purdue, paid billions in settlements but avoided criminal prosecution through bankruptcy proceedings.
  • The epidemic has three waves: prescription opioids (1990s-2010), heroin (2010-2013), and synthetic fentanyl (2013-present) — which is now responsible for most overdose deaths.

AI Summary

Key takeaways highlight The opioid epidemic killed over 500,000 Americans between 1999 and 2020, with deaths continuing at high rates driven by illicit fentanyl. Purdue Pharma aggressively marketed OxyContin knowing it was highly addictive, used misleading claims about its safety, and paid doctors to prescribe it. The Sackler family, which owned Purdue, paid billions in settlements but avoided criminal prosecution through bankruptcy proceedings. The epidemic has three waves: prescription opioids (1990s-2010), heroin (2010-2013), and synthetic fentanyl (2013-present) — which is now responsible for most overdose deaths.

What Is the Opioid Crisis and Did Anyone Go to Jail?

More Americans have died from opioid overdoses since 1999 than in all US wars combined. The epidemic was knowingly created by a pharmaceutical company. Its owners profited enormously. Almost none of them went to prison.

This is one of the most consequential corporate crimes in American history — and one of the clearest examples of how wealth translates into legal protection.

How Purdue Pharma Created a Crisis

In 1996, Purdue Pharma — a private company owned by the Sackler family — launched OxyContin, an extended-release version of oxycodone.

The marketing campaign was sophisticated and deliberately misleading. Purdue trained sales representatives to tell doctors that OxyContin was less addictive than other opioids because of its extended-release formulation. Internal documents later revealed in litigation showed the company knew this claim was false — the drug was highly addictive, and its abuse potential was well understood internally.

Purdue paid doctors to prescribe OxyContin through speaking fees and other arrangements. It pushed for expansion of opioid use into non-cancer chronic pain patients — a vast market that prior medical norms had treated cautiously with opioids because of addiction risk.

The FDA approved OxyContin based on inadequate clinical evidence. Regulators at the agency responsible for approving the drug subsequently took positions at or benefiting the pharmaceutical industry.

The Three Waves

The opioid epidemic is now understood as three overlapping waves:

Wave 1 (1990s-2010): Prescription opioid addiction. Millions of patients given OxyContin and other prescription opioids became physically dependent. Deaths from prescription opioid overdose rose sharply through the 2000s.

Wave 2 (2010-2013): As prescription monitoring programs tightened and OxyContin reformulated to be harder to abuse, addicted patients who could no longer get prescriptions turned to heroin — cheaper and more available. Heroin overdose deaths spiked.

Wave 3 (2013-present): Illicit fentanyl, manufactured primarily in China and Mexico, entered the illicit drug supply. Fentanyl is 50-100 times more potent than morphine. It began appearing mixed into heroin without users' knowledge. Then into cocaine. Then into counterfeit pills made to look like prescription oxycodone. Drug users who thought they were taking familiar substances were actually taking fentanyl. Deaths exploded.

The fentanyl wave is the deadliest phase. Approximately 80,000-110,000 Americans die from overdoses each year in recent data, the vast majority involving fentanyl.

The Accountability Failure

Purdue Pharma paid approximately $8 billion in settlements and pleaded guilty to federal criminal charges. The company was dissolved in bankruptcy.

The Sackler family personally extracted approximately $11 billion from Purdue before its bankruptcy — much of it transferred to overseas accounts after litigation began. In the bankruptcy proceedings, they negotiated a settlement providing billions in payments in exchange for civil immunity — meaning individuals and states who were harmed couldn't sue them personally.

The Supreme Court struck down the immunity provisions in 2024 (Harrington v. Purdue Pharma), holding that non-debtor parties (the Sackler family members who hadn't personally filed for bankruptcy) couldn't use bankruptcy proceedings to buy immunity from civil suits they hadn't themselves filed.

Criminal prosecution of Sackler family members: none. Individual family members were not charged with crimes related to their company's role in the epidemic.

The contrast with other criminal contexts is stark: low-level drug users who sell small amounts of opioids face federal mandatory minimums of 5-10 years. The people who created the market for addiction, who knowingly misled doctors and patients about addiction risk, who extracted billions in profits — face civil settlements and no prison time.

Whether this represents justice is not a complicated question.

What Changed

States have enacted opioid settlement requirements. Purdue's bankruptcy produced $6+ billion in settlement funds distributed to states for addiction treatment and prevention.

The DEA has significantly tightened prescription monitoring. Electronic prescription databases have made "doctor shopping" harder. Prescriptions for opioids have declined dramatically since their 2012 peak.

But the addiction population created in the 1990s-2000s has largely transitioned to illicit fentanyl. Reducing prescription opioid access didn't reduce the epidemic — it transformed it into a more lethal phase.

The public health response that evidence supports: expanded naloxone (overdose reversal medication) access, expanded medication-assisted treatment (methadone, buprenorphine) without the regulatory barriers that currently limit it, harm reduction programs (clean needles, fentanyl test strips), and treatment funding from the opioid settlements.

Mortality rates have begun declining in some states with robust harm reduction programs. The tools exist. The question is whether the political will to use them — which requires treating addiction as a health issue rather than a moral failure — is sufficient.

FAQ

How did the opioid crisis start?

The opioid crisis originated from aggressive pharmaceutical marketing of prescription opioids in the 1990s, primarily OxyContin by Purdue Pharma, launched in 1996. Purdue paid doctors to prescribe opioids, marketed them with misleading claims about low addiction risk, and pushed for use in non-cancer pain — far beyond prior medical norms. The FDA approved the drug based on inadequate evidence. Millions of patients became addicted to prescription opioids; when prescriptions became harder to obtain, many transitioned to heroin and eventually illicit fentanyl.

Did the Sackler family go to jail?

No. Members of the Sackler family, which owned Purdue Pharma and personally profited from OxyContin sales, have not faced criminal prosecution. Purdue Pharma pleaded guilty to federal criminal charges in 2020 and was dissolved. The Sackler family negotiated a settlement in bankruptcy proceedings that provided billions in payments in exchange for immunity from civil suits. The Supreme Court in 2024 struck down the immunity provisions of that settlement, requiring new bankruptcy negotiations, but criminal prosecution of individual Sackler family members has not occurred.

What is fentanyl and why is it so deadly?

Fentanyl is a synthetic opioid 50-100 times more potent than morphine, originally developed for severe cancer pain. Illicit fentanyl, primarily manufactured in China and Mexico and smuggled into the US, has become the dominant driver of overdose deaths since 2016. Its extreme potency means a dose the size of a few grains of salt can be lethal. It is often added to other drugs (heroin, cocaine, counterfeit pills) without users' knowledge. Illicit fentanyl now causes over 70,000 overdose deaths per year.

How many people die from opioids each year in the US?

Approximately 80,000-110,000 Americans die from drug overdoses each year (2022-2025 data), with opioids — primarily illicit fentanyl — involved in roughly 75-80% of deaths. This is more deaths than all car accidents, more than gun violence, and significantly more than died in the Vietnam War per year. Overdose deaths have increased dramatically since 2013 when fentanyl began appearing in the illicit drug supply.